Robert F. Apple, President & CEO at ANTARES PHARMA, INC. (ATRS), sold 43,000 shares at $3.75 ($161K) on 2018-08-21, disclosed to the SEC on 2018-08-23.
Open-market sale of $161k ATRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2019-12-11 | $2.0M | — | Filing → |
| ATRS | SELL | 2017-04-05 | $120K | — | Filing → |
| ATRS | BUY | 2016-03-18 | $43K | — | Filing → |